Timothy A. Springer, Angel Investor

Timothy Springer is an active Angel Investor, Scientist, Entrepreneur, and Professor at Harvard University He is advancing open-source antibodies, science & therapeutics by founding the Institute for Protein Innovation. Springer has been an investor in Selecta Bioscience since its B round and a founding investor in Moderna Therapeutics. He is the founder and investor in Scholar Rock and Morphic Rock Therapeutics. Current projects include a non-profit to produce open-source, synthetic antibodies to all extracellular proteins to speed therapeutic development and improve basic research globally. Another project is a dual-acting malaria vaccine, to both protect humans from being infected and to prevent mosquitos from transmitting infection.